✦ LIBER ✦

499 POSTER Identification of a PARP inhibitor for clinical trial: preclinical studies

✍ Scribed by H. Thomas; C. Calabrese; S. Canan; Z.K.S. S; K. Maegley; D. Newell; D. Skalitzki; L. Wang; N. Curtin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Climbing STAIRs towards clinical trials

✍ Andria L. Ford; Jin-Moo Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 137 KB

552 POSTER Targeting MET with XL184 to r

✍ P.A. Janne; M. Wax; J. Leach; J. Engelman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

439 POSTER MKC-1 a novel cell cycle inhi

✍ T. LaVallee; R. Brokx; P. Burke; G. Fletcher; S. Plum; W. Fogler; A. Treston; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

81 POSTER Preclinical pharmacodynamic ma

✍ N. Beaulieu; I. Dupont; C. Beaulieu; H. Nguyen; H. Ste-Croix; S. Claridge; L. Is 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The Importance of Preclinical Trial Timi

✍ Qiongman Kong; Sarah Carothers; Yueming Chang; Chien-Liang Glenn Lin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

1311 POSTER Written Information for Rese

✍ M. Weidstam; A.C. Mattiasson; M. Bergenmar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB